Home  /  Resource Library  /  Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)

Results of a study investigating lenalidomide plus chemotherapy for previously untreated chronic lymphocytic leukemia.